![PDF) Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine PDF) Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine](https://i1.rgstatic.net/publication/5476747_Booster_vaccination_at_6-8_years_of_age_with_a_reduced_antigen_content_dTpa-IPV_vaccine_is_immunogenic_and_safe_after_priming_with_whole-cell_pertussis_vaccine/links/0fcfd511a546ad9c78000000/largepreview.png)
PDF) Booster vaccination at 6-8 years of age with a reduced antigen content dTpa-IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine
Full article: Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b vaccine; Infanrix™ hexa
![A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ... A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X18303669-gr1.jpg)
A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella ...
![PDF) Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV) PDF) Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)](https://i1.rgstatic.net/publication/44578883_Repeated_administration_of_a_reduced-antigen-content_diphtheria-tetanus-acellular_pertussis_and_poliomyelitis_vaccine_dTpa-IPV_Boostrix_IPV/links/57079c9e08aed09e916d13cd/largepreview.png)
PDF) Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV)
AUSTRALIAN PRODUCT INFORMATION BOOSTRIX-IPV (combined diphtheria, tetanus, acellular pertussis (dTpa) and inactivated polioviru
Booster vaccination at 6-8 years of age with a reduced antigen content dTpa- IPV vaccine is immunogenic and safe after priming with whole-cell pertussis vaccine: Human Vaccines: Vol 4, No 1
![Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults - ScienceDirect Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0264410X15004430-gr2.jpg)
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults - ScienceDirect
Infanrix hexa, INN-Diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (
e150 13th International Congress on Infectious Diseases Abstracts, Poster Presentations 19.026 Co-Administration of GSK's AS04
![The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses - eClinicalMedicine](https://www.thelancet.com/cms/asset/2af9ebf0-07eb-43a8-8696-b13d8cf0641d/gr1.jpg)